Prevention of pectus excavatum for children with spinal muscular atrophy type 1

John R Bach1, Carlo Bianchi

  • 1Department of Physical Medicine and Rehabilitation and Neurosciences UMDNJ- New Jersy Medical School, Newark, New Jersey 07103, USA.

Insights

High-span positive inspiratory pressure plus positive end-expiratory pressure (PIP+PEEP) can resolve pectus excavatum in infants with spinal muscular atrophy type 1. This intervention promotes normal lung and chest wall development in affected infants.

Area of Science:

  • Pediatric Pulmonology
  • Neuromuscular Disorders
  • Respiratory Physiology

Background:

  • Spinal muscular atrophy type 1 (SMA1) is a severe genetic disorder characterized by progressive muscle weakness.
  • Infants with SMA1 often exhibit paradoxical breathing and pectus excavatum, impacting respiratory function and chest wall development.
  • Current treatments for SMA1 focus on disease modification, with limited options for managing respiratory complications.

Observation:

  • Pectus excavatum is a near-universal finding in untreated infants diagnosed with SMA1.
  • Paradoxical breathing patterns are common in infants with SMA1 due to respiratory muscle weakness.
  • Early intervention with non-invasive ventilation is crucial for managing respiratory distress in these patients.

Findings:

  • The application of high-span positive inspiratory pressure plus positive end-expiratory pressure (PIP+PEEP) during sleep effectively eliminated pectus excavatum in infants with SMA1.
  • Consistent use of high-span PIP+PEEP from diagnosis led to more normalized lung growth and chest wall development.
  • This non-invasive ventilatory strategy demonstrated a significant positive impact on thoracic structure and pulmonary function.

Implications:

  • High-span PIP+PEEP should be considered a standard supportive therapy for all infants diagnosed with SMA1 who present with paradoxical breathing.
  • Implementing this intervention early can mitigate severe chest wall deformities and improve long-term respiratory outcomes.
  • Further research should explore the long-term effects of PIP+PEEP on pulmonary capacity and overall quality of life in SMA1 patients.